Thalys Medical Technology Group Balance Sheet Health
Financial Health criteria checks 2/6
Thalys Medical Technology Group has a total shareholder equity of CN¥1.1B and total debt of CN¥1.1B, which brings its debt-to-equity ratio to 96.1%. Its total assets and total liabilities are CN¥3.1B and CN¥2.0B respectively.
Key information
96.1%
Debt to equity ratio
CN¥1.10b
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥253.62m |
| Equity | CN¥1.14b |
| Total liabilities | CN¥1.99b |
| Total assets | CN¥3.13b |
Financial Position Analysis
Short Term Liabilities: 603716's short term assets (CN¥2.3B) exceed its short term liabilities (CN¥1.4B).
Long Term Liabilities: 603716's short term assets (CN¥2.3B) exceed its long term liabilities (CN¥630.8M).
Debt to Equity History and Analysis
Debt Level: 603716's net debt to equity ratio (74%) is considered high.
Reducing Debt: 603716's debt to equity ratio has increased from 49.7% to 96.1% over the past 5 years.
Debt Coverage: 603716's debt is not well covered by operating cash flow (2.5%).
Interest Coverage: Insufficient data to determine if 603716's interest payments on its debt are well covered by EBIT.